CYP2J2*7SNP与心血管疾病相关性的研究现状

被引：1

作者：

詹同运

石磊

赵树进

机构：

[1] 广州军区总医院药剂科

来源：

生物学杂志 | 2011年 / 28卷 / 04期

基金：

广东省科技计划;

关键词：

细胞色素P450; 基因多态性; 心血管疾病; CYP2J2;

D O I：

暂无

中图分类号：

R54 [心脏、血管（循环系）疾病];

学科分类号：

1002 ; 100201 ;

摘要：

花生四烯酸的CYP450环氧化物酶(主要是CYP2C和2J亚家族)代谢物EETs具有心血管保护作用,包括血管扩张、抗炎、抗血栓、抗细胞凋亡、促进缺血组织平滑肌细胞生长及血管生成等作用。而基因多态性会导致酶活性的下降或酶合成量的减少,使得相应代谢物合成量减少,并可能与疾病的发生息息相关。因此科研工作者从基因出发,寻找疾病的易感基因,以期从分子水平治疗疾病。CYP450环氧化物酶基因突变的位点很多,仅就其花生四烯酸代谢产物之一EETs在心血管中的作用和CYP2 J2中一个普遍存在且具有功能意义的突变点G-50T(即CYP2 J2*7)单核苷酸多态性与心血管疾病关系的研究现状作一综述。

引用

页码：81 / 83

页数：3

共 19 条

[1]

The-50G>T Polymorphism in the Promoter of the CYP2J2 Gene inCoronary Heart Disease:The Ludwigshafen Risk and Cardiovascu-lar Health Study. HOFFMANN M M,BUGERT P,SEELHORST U,et al. Clinical Chemistry . 2007

[2]

The prevalence of CYP2C8,2C9,2J2,and soluble epoxide hydrolase polymorphisms in African Americanswith hypertension. Dreisbach AW,Japa S,Sigel A,et al. American Journal of Hypertension . 2005

[3]

CYP2J2*7single nucleotide poly-morphism in a Chinese population. Wang H,,Jiang Y,Liu Y,et al. Clinica Chimica Acta . 2006

[4]

Common variation in cy-tochrome P450 epoxygenase genes and the risk of incident nonfatal myocar-dial infarction and ischemic stroke. Marciante K D,Totah R A,Heckbert S R,et al. Pharmacogenetics Genomics . 2008

[5]

The common functional poly-morphism-50G>T of the CYP2J2 gene is not associated with ischemiccoronary and cerebrovascular events in an urban-based sample of Swedes. Fava C,Montagnana M,Almgren P,et al. Journal of Hypertension . 2010

[6]

The Prevalence of CYP2C8, 2C9, 2J2, and Soluble Epoxide Hydrolase Polymorphisms in African Americans With Hypertension[J] . Albert W. Dreisbach,Shanker Japa,Aster Sigel,Melissa B. Parenti,Arthur E. Hess,Sengkeo L. Srinouanprachanh,Allan E. Rettie,Helen Kim,Federico M. Farin,L. Lee Hamm,Juan J.L. Lertora. &nbspAmerican Journal of Hypertension . 2005 (10)

[7]

CYP2J2 * 7 single nucleotide polymorphism in a Chinese population[J] . Haijian Wang,Yan Jiang,Yang Liu,Chengzhao Lin,Gang Cheng,Xiaoping Chen,Bingtao Hao,Wen Tan,Dongxin Lin,Fuchu He. &nbspClinica Chimica Acta . 2006 (1)

[8] Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke [J].

Marciante, Kristin D. ;

Totah, Rheern A. ;

Heckbert, Susan R. ;

Smith, Nicholas L. ;

Lemaitre, Rozenn N. ;

Lumley, Thomas ;

Rice, Kenneth M. ;

Hindorff, Lucia A. ;

Bis, Joshua C. ;

Hartman, Brittany ;

Psaty, Bruce M. .

PHARMACOGENETICS AND GENOMICS, 2008, 18 (06) :535-543

[9]

CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study. LEE CR,NORTH KE,BRAY MS, et al. Pharmacogenet Genomics . 2007

[10]

The CYP2J2 G-50Tpolymorphism and myocardial infarction in patients with cardiovascularrisk profile. BRGEL J,BULUT D,HANEFELD C,et al. Cardiovasc Disord . 2008

← 1 2 →